[

sputnik v vaccine

]
Sputnik V vaccine is developed by Russia’s Gamaleya Institute with assistance from the Russian sovereign wealth fund (RDIF).(Reuters File Photo)

Sputnik V rollout delayed in Delhi, hospitals point to supply issues

By hindustantimes.com | Edited by Amit Chaturvedi, Hindustan Times, New Delhi
PUBLISHED ON JUN 20, 2021 01:22 PM IST
Sputnik V is the third vaccine to get emergency use approval from India's drugs regulator DCGI. The other two vaccines are AstraZeneca's Covishield and Bharat Biotech's Covaxin.
In this file photo taken on May 09, 2021, a medical worker displays a vial of the Covaxin vaccine against the Covid-19 coronavirus at a vaccination center in Mumbai. (AFP)
In this file photo taken on May 09, 2021, a medical worker displays a vial of the Covaxin vaccine against the Covid-19 coronavirus at a vaccination center in Mumbai. (AFP)

Brazil clears proposal to import Covaxin, Sputnik V; conditions apply

PUBLISHED ON JUN 05, 2021 10:00 PM IST
The clarification regarding GMP comes as the Brazillian health regulator had earlier denied the proposal to import Covaxin into the country, after the authorities found that the Indian plant in which the Covid-19 vaccine was being made did not meet the GMP requirements.
A health worker prepares a dose of the Sputnik V vaccine against Covid-19 (Representational Image / AFP)
A health worker prepares a dose of the Sputnik V vaccine against Covid-19 (Representational Image / AFP)

DCGI allows Serum Institute to manufacture Sputnik V vaccine in India

By hindustantimes.com | Written by Joydeep Bose
PUBLISHED ON JUN 04, 2021 09:10 PM IST
The Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, in Russia for developing Sputnik V at its licensed Hadapsar facility.
A medical worker holds a box of Sputnik V vaccine against the coronavirus disease (Covid-19) in Moscow.(Reuters File Photo)
A medical worker holds a box of Sputnik V vaccine against the coronavirus disease (Covid-19) in Moscow.(Reuters File Photo)

Serum Institute of India applies to DCGI to manufacture Covid vaccine Sputnik V

By hindustantimes.com | Edited by Amit Chaturvedi, Hindustan Times, New Delhi
PUBLISHED ON JUN 03, 2021 12:18 PM IST
Sputnik V is the third Covid-19 vaccine to be approved by India's drugs regulator DCGI after Bharat Biotech's Covaxin and Covishield, which is manufactured by Serum Institute of India (SII).
A health worker shows vials of Russian Sputnik V vaccines against Covid-19. (File Photo)
A health worker shows vials of Russian Sputnik V vaccines against Covid-19. (File Photo)

India likely to receive Sputnik V Covid-19 vaccines from Russia on May 1

By hindustantimes.com | Written by Joydeep Bose
PUBLISHED ON APR 27, 2021 10:49 AM IST
Although the RDIF chief did not specify how many of Russian Sputnik V vaccines against Covid-19 would there be in the first batch, it was reported that the sovereign wealth fund has already signed agreements with five leading Indian manufacturers for over 850 million doses of the vaccine a year.
The company can produce nearly 40 million vials of vaccines annually at its facility in Hyderabad. (Bloomberg/For Representative Purposes Only)
The company can produce nearly 40 million vials of vaccines annually at its facility in Hyderabad. (Bloomberg/For Representative Purposes Only)

Gland sets 252 million Sputnik V doses target

By Leroy Leo, Livemint, New Delhi
PUBLISHED ON MAR 17, 2021 08:12 AM IST
  • The company can produce nearly 40 million vials of vaccines annually at its facility in Hyderabad and is ready to scale up capacity if needed.
A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine as she prepares to vaccinate a Russian Army service member at a clinic in the city of Rostov-On-Don, Russia.(REUTERS)
A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine as she prepares to vaccinate a Russian Army service member at a clinic in the city of Rostov-On-Don, Russia.(REUTERS)

Palestinians approve Russian Covid-19 vaccine for use in self-rule areas

Reuters |
PUBLISHED ON JAN 11, 2021 10:28 PM IST
The first shipment of the Russian shot is expected to arrive next month, with all deliveries expected in the first quarter of this year, according to the Russian Direct Investment Fund, which is responsible for marketing the vaccine abroad.
A nurse prepares Russia's Sputnik-V vaccine against the coronavirus disease (Covid-19) for inoculation at a clinic in Tver, Russia.(Reuters)
A nurse prepares Russia's Sputnik-V vaccine against the coronavirus disease (Covid-19) for inoculation at a clinic in Tver, Russia.(Reuters)

First batch of Sputnik V vaccine to arrive in Kanpur medical college for Phase 2, 3 trials

Press Trust of India | By Press Trust of India | Posted by Mallika Soni
UPDATED ON NOV 15, 2020 02:05 PM IST
The human clinical trials of the vaccine will start from next week for which more than 180 volunteers have registered so far.
SHARE
Story Saved